Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis
Authors:
- M. HuiMHM. Hui
- C. Au-YeangCAC. Au-Yeang
- K.T. WongKWK.T. Wong
- C.Y. ChanCCC.Y. Chan
- W.W. YewWYW.W. Yew
- C.C. LeungCLC.C. Leung
- 30 April 2008
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 31 (4) , 395-396
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- In Vitro Postantibiotic Effects of Rifapentine, Isoniazid, and Moxifloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2004
- Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2003
- Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone AntibacterialClinical Pharmacokinetics, 2003
- In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous DrugsAntimicrobial Agents and Chemotherapy, 2003
- Postantibiotic Effects of Antituberculosis Agents Alone and in CombinationAntimicrobial Agents and Chemotherapy, 2001
- In-vitro activity of quinolones and macrolides against mycobacteriaJournal of Antimicrobial Chemotherapy, 1994